Argenx
ARGX
#652
Rank
HK$249.36 B
Marketcap
HK$4,170
Share price
1.79%
Change (1 day)
5.40%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: HK$249.36 Billion

As of October 2024 Argenx has a market cap of HK$249.36 Billion. This makes Argenx the world's 652th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024HK$249.36 B41.49%
2023HK$176.24 B7.63%
2022HK$163.75 B14.19%
2021HK$143.39 B31.92%
2020HK$108.69 B102.91%
2019HK$53.57 B95.11%
2018HK$27.45 B75.28%
2017HK$15.66 B
2014HK$1.12 B

End of Day market cap according to different sources

On Oct 11th, 2024 the market cap of Argenx was reported to be:

HK$249.36 Billion
by Yahoo Finance info icon info icon
HK$249.36 Billion
by CompaniesMarketCap info icon info icon
HK$246.85 Billion
by Nasdaq info icon info icon